- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 4 granted · 36 pending
- Sector median: 2
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1300 | TOMEGAVAX, INC. | — | — |
| 1301 | Windward Bio | — | — |
| 1302 | Azalea Therapeutics | — | — |
| 1303 | Maze Therapeutics | — | — |
| 1304 | LUNG THERAPEUTICS INC | — | — |
| 1305 | Immunomedics | — | — |
| 1306 | INVENIO THERAPEUTICS INC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Inhibitors Of Glycogen Synthase 1 (GYS1) And Methods Of Use Thereofapplication
- Inhibitors Of Solute Carrier Family 6A Member 19 (SLC6A19) And Methods Of Use Thereofapplication
- Inhibitors Of Solute Carrier Family 6A Member 19 (SLC6A19) And Methods Of Use Thereofapplication
- Dimeric Compounds As Inhibitors Of Glycogen Synthase 1 (GYS1) And Methods Of Use Thereofapplication
- N-(benzhydryl)cycloalkylcarboxamide Derivatives As Inhibitors Of Glycogen Synthase 1 (GYS1) And Methods Of Use Thereofapplication
- APOL1 Inhibitors And Methods Of Useapplication
- Inhibitors Of Glycogen Synthase 1 (GYS1) And Methods Of Use Thereofgranted
- Cycloalkyl Carboxylic Acid Derivatives As Inhibitors Of Glycogen Synthase 1 (GYS1) And Methods Of Use Thereofapplication
- APOL1 Inhibitors And Methods Of Uses Thereofapplication
- APOL1 Inhibitors And Methods Of Useapplication
- APOL1 Inhibitors And Methods Of Usegranted
- Compositions And Methods For Treating TDP-43 Proteinopathyapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.